fda glp-1 compounding enforcement september 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our Florida's New Compounding Bill Lands

[7] Dietary changes associated with GLP-1/GIP treatment may also contribute to reduced B12 intake

To add some data to this important discussion on oral GLP-1 research, I pulled an evidence-backed synthesis from Cheiron on the scientific and clinical challenges in developing effective oral GLP-1 therapies: [ Its a compelling look at why this complex science cant be rushed or shortcut

115 Additionally, TZDs have been shown to be the least effective in diminishing BMI

The statements made in this article have not been evaluated by the Food and Drug Administration (FDA)

The Pubmed database was searched for the following MeSH terms: glp1, glp 1, glucagon like peptide 1 receptor agonist, exenatide, lixisenatide, albiglutide, liraglutide, semaglutide or dulaglutide, and drug drug interaction or pharmacokinetic(s)

They ferment the leftovers, especially foods high in sulfur, like eggs, red meat, and cruciferous vegetables This process produces hydrogen sulfide as waste